MSI Lab Per Andrén joins SciLifeLab Spatial Omics
With the launch of national resource Spatial Omics, SciLifeLab consolidates Sweden's advanced position in one of the hottest fields of science. "This gives us the capacity to extract even more detailed knowledge from cell and tissue analyses," states Professor Per Andrén, whose MSI environment is recruited to the new infrastructure.
Spatial Omics is a relatively young area of technology that is quickly becoming a very important part of Life Science. With powerful instruments and large-scale cell analyses in tissue samples, data are generated that constitute key tools for research in fields such as cancer, immunology and neurology. Sweden holds a prominent position in this field and now SciLifeLab is taking the next step with the launch of a national resource for Spatial Omics. The new infrastructure brings together several leading environments, among them Per Andréns' laboratory for Mass Spectrometry Imaging, MSI, at Uppsala University.
“Spatial Omics combines different technologies that together generate a wide range of molecular information, and this new collaboration will give us the capacity to extract extremely detailed molecular knowledge. Our goal is to be able to image individual cells in tissue sections, identify how they are placed in relation to each other and to define their individual tasks and status,” says Per Andrén, Professor of Mass Spectrometry Imaging.
SciLifeLab Spatial Mass Spectrometry is part of the new Spatial and Single Cell Biology platform. Using state-of-the-art instruments, the aim it to automate both the processing and the analysis of samples. A development that will enable both upscaling of quantities and increase the precision in data output. A joint application from four of the units in the platform recently resulted in 29 million SEK funding, resources that are currently being invested in addition to existing instrumentation and expertise.
“Our laboratory in Uppsala is already one of the world's leader in MSI with tools so powerful that the information they generate can be so detailed and complex that they are at times difficult to comprehend. We are now preparing the acquisition of instruments that will further improve spatial resolution and strengthen our capacity to distinguish molecules of identical weight. In parallel, we have initiated recruitments in software development and bioinformatics. In 2022, we expect to have everything in place,” says Per Andrén.
The new infrastructure is primarily a resource for Swedish academic research, but assignments from industry and abroad can be accepted to a certain extent. With the increased capacity to process information, SciLifeLab Spatial Omics will remove the bottleneck that often occur when projects are ready to upscale their production of data. In the foreseeable future, the ambition is to contribute to in-depth understanding of disease mechanisms, more sensitive diagnostics, new drugs and better treatment strategies.
“Our facility is already internationally sought after with a waiting list for our services. Nevertheless, SciLifeLab provides us now with a completely new platform to visualize our facility and to identify new projects where we can contribute to maximise the outcome of good and relevant research. We also have great faith in the synergy effects we identify in a common infrastructure, which will hopefully in the long run attract even more researchers to conduct their studies in Sweden.”
FACTS SCILIFELAB SPATIAL OMICS
- Offers access to technology for spatially resolved RNA, protein and small molecule analyses of histological tissue sections.
- Comprises expertise in
In Situ Sequencing
Advanced FISH Technologies
Spatial Mass Spectrometry
- SciLifeLab Spatial Omics
- Research in Medical Mass Spectrometry at Uppsala university
- Uppsala's MSI environment continues to expand
Per Andrén, Professor of Mass Spectrometry Imaging
Department of Pharmaceutical Biosciences
text: Magnus Alsne, photo: Mikael Wallerstedt, SciLifeLab
SEK 25 million to ENABLE-2 and continued development of new antibiotics
2021-10-06ENABLE, the EU initiative for antibiotic development led by Uppsala University, has received SEK 25 million from the Swedish Research Council to start up ENABLE-2. "We are already accepting project proposals and hope that this investment will inspire...
MSI Lab Per Andrén joins SciLifeLab Spatial Omics
2021-09-16With the launch of national resource Spatial Omics, SciLifeLab consolidates Sweden's advanced position in one of the hottest fields of science. "This gives us the capacity to extract even more detailed knowledge from cell and tissue analyses," states...
Webinar about your possibilities at Testa Center
2021-09-14Testa Center provides Uppsala University’s researchers access to state-of-the-art equipment for drug and bioprocess development. At the webinar "Academic research in the Testa Center – A testing bed for upscaling your biological innovations", you w...
Andrea Benediktsdottir is awarded the Iris Scholarship for aspiring women
2021-08-13Andrea Benediktsdottir, PhD student at the Department of Medicinal Chemistry, is awarded the Iris Scholarship for aspiring women in Sweden. With the scholarship, Andrea Benediktsdottir will participate in an interdisciplinary course focusing on antib...
SciLifeLab – A national research infrastructure in Uppsala
2021-06-18SciLifeLab is a national research infrastructure in life sciences with Uppsala University as one of four host universities. Today, SciLifeLab conducts operations at most major Swedish universities. ...
New research to improve use of amphiphilic drug molecules
2021-05-19By exploring the aggregation properties of different amphiphilic molecules in microgels, Yassir Al-Tikriti, PhD student at the Department of Medicinal Chemistry, aims to provide tools and knowledge of importance for future cancer therapies and antide...
New seminar series puts focus on Swedish drug development
2021-04-19This spring semester, SweDeliver and NextBioForm invite to online lunch seminars. Welcome to experience frontline research with a focus on industrial challenges in drug delivery and the development of biologically based drugs. ...
Olof Eriksson receives SEK 1,3 million for PET project
2021-04-19Olof Eriksson, researcher in translational imaging, is awarded a Project Grant of SEK 1,303,000 from Diabetes Wellness Sweden for his project GPR44 as a PET marker for measuring beta cell mass in human. ...
New biomarkers can lead to breakthrough in diabetes research
2021-04-19With the discovery of two new biomarkers, Olof Eriksson, researcher in translational imaging, may lead the way to the scientific breakthrough that will enable curative drugs and personalised treatments for diabetes. ...
Apply for funding for postdoc exchange between the Faculty of Pharmacy and SLU
2021-04-19Funding is now available for two postdoc exchanges, one hosted by the Faculty of Pharmacy or Fauculty of Medicine at Uppsala University, and one by a department at the SLU Faculty of Veterinary Medicine and Animal Science ...
Here you can read more research news at the Department of Medicinal Chemistry